Axios @axios
Patients, doctors and insurers still have to decide whether using the drug to slow the disease's progression is worth the associated hassle, cost and safety risks. https://t.co/CFphgTAGYC — PolitiTweet.org
Created
Tue Jan 10 19:35:43 +0000 2023
Likes
6
Retweets
3
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
Patients, doctors and insurers still have to decide whether using the drug to slow the disease's progression is worth the associated hassle, cost and safety risks. https://t.co/CFphgTAGYC — PolitiTweet.org